Position in MRNA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$794,700
-$426,430 QoQ
Shares Held
11,348
-52.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#46
of 185 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$5,952,550
PutShares
85,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CREDIT INDUSTRIEL ET COMMERCIAL holds $25,265,040 across 7 Biotechnology names. MRNA ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
63,424 | $8,418,267 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
193,503 | $6,081,799 | |
| 3 | NUVL |
Nuvalent, Inc.
|
43,670 | $5,393,245 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
33,013 | $1,889,003 | |
| 5 | XOMA |
XOMA Royalty Corp
|
34,853 | $1,481,252 | |
| 6 | RNA |
Atrium Therapeutics, Inc.
|
89,723 | $1,206,774 | |
| 7 | MRNA |
Moderna, Inc.
This page
|
11,348 | $794,700 |
All Filings in MRNA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,952,550 | 85,000 | Put | Defined | 2026-07-24 | |
| 2026-06-30 | $794,700 | 11,348 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $1,221,130 | 24,038 | Shares | Defined | 2026-04-29 | |
| 2026-03-31 | $4,318,000 | 85,000 | Put | Defined | 2026-04-29 | |
| 2025-12-31 | $150,310 | 5,097 | Shares | Defined | 2026-02-03 | |
| 2025-12-31 | $737,250 | 25,000 | Put | Defined | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||